Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Spremljanje bolnikov z MRSA na Onkološkem inštitutu v Ljubljani
Authors:ID Kerin-Povšič, Milena (Author)
Files:.pdf PDF - Presentation file, download (112,11 KB)
MD5: AD13D7F89A9BE7F1E8FCFD882FB34F81
PID: 20.500.12556/dirros/23f99848-8f69-4f76-b1e4-ea4a9e4363b2
 
Language:Slovenian
Typology:1.04 - Professional Article
Organization:Logo OI - Institute of Oncology
Abstract:Meticilin rezistenten Staphylococcus aureus (MRSA) je pomemben povzročitelj bolnišničnih okužb. Širi se predvsem prek rok zdravstvenega osebja in bolnikov. Možnosti antibiotičnega zdravljenja so omejene. Najpogosteje uporabljamo glikopeptidne antibiotike, ki imajo slab baktericidni učinek. Onkološki bolniki imajo zaradi bolezni in postopkov zdravljenja oslabljene obrambne mehanizme, zato so bolj nagnjeni k okužbam. Dodatni dejavniki tveganja za okužbo so slaba prehranjenost, invazivni diagnostični in terapevtski posegi, pogoste hospitalizacije itd. Pomembno je dosledno izvajanje ukrepov za preprečevanje širjenja MRSA: higiena rok, iskanje bolnikov z dejavniki tveganja za nosilstvo MRSA, izolacija in dekolonizacija bolnika ter racionalna uporaba antibiotikov. Pogostnost pojavljanja MRSA je kazalec uspešnosti bolnišnične higiene. Na Onkološkem inštitutu izvajamo aktivno iskanje bolnikov z dejavniki tveganja od leta 2004. Prisotnost MRSA je bila največkrat ugotovljena v pooperativni ali kronični rani. Najpogostejši dejavnik tveganja je predhodna hospitalizacija, zlasti na kirurških oddelkih. Število bolnikov z MRSA v zadnjih letih upada.
Publication status:Published
Publication version:Version of Record
Year of publishing:2009
Number of pages:str. 22-25
Numbering:Letn. 13, št. 1
PID:20.500.12556/DiRROS-8739 New window
UDC:616-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-7DC5K4MH
COBISS.SI-ID:25704665 New window
Copyright:by Authors
Note:BSDOCID145248;
Publication date in DiRROS:31.08.2018
Views:3307
Downloads:766
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:Follow up of MRSA Patients at the Institute of Oncology Ljubljana
Abstract:Methicillin-resistant Staphylococcus aureus (MRSA) is considered to be the most frequent agent of nosocomial infections. It may be spread through physical contacts of hospital staff with patients. Antibiotic treatment possibilities are limited. Most frequently, glycopeptides antibiotics are used; however, their bactericidal effect is inadequate. Cancer patients are known to have weakened immune systems due to the disease itself and also to cancer therapies. They are therefore at greater risk for infection than other patients. Additional infection risks in cancer patients are also undernourishment, invasive diagnostic and therapeutic interventions, frequent hospitalizations, etc. In the prevention of further spread of MRSA, it is of utmost importance to follow strictly the measures, such as hand hygiene, identification of patients who are at risk to be MRSA carriers, isolation and decolonization of the patients at risk and sensible use of antibiotics. The data on MRSA occurrence in a hospital are viable indicators of the level of hospital hygiene. At the Institute of Oncology Ljubljana, regular identification of patients who are at risk of infection with MRSA has been carried out from 2004. Most frequently, MRSA has been detected in a surgical or chronic wound and the most frequent risk factor has been hospitalization, in particular at surgical wards. Fortunately, the MRSA incidence has been found to decline in most recent years.


Archive

niGradiv

Back